Merck & (MRK) Revenue — Quarter Ended Sep 30, 2024
The company reported an increase in revenue for the quarter. This growth was seen both sequentially and compared to the same period last year.
Key takeaway
Quarter ended Sep 30, 2024 · FY2024 Q3
The company reported an increase in revenue for the quarter. This growth was seen both sequentially and compared to the same period last year.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$16.7B
Revenue reported for this quarter.
Quarter-over-quarter
+3.4%
Change from the immediately preceding quarter.
Year-over-year
+4.4%
Change from the comparable year-ago quarter.
Trailing four quarters
$63.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2023 | $14.6B | +5.8% |
| Mar 31, 2024 | $15.8B | +8.9% |
| Jun 30, 2024 | $16.1B | +7.2% |
| Sep 30, 2024 | $16.7B | +4.4% |
Revenue performance
Revenue rose compared to the immediately preceding quarter, as well as the year-ago quarter.
Quarterly comparison
The revenue increase was sustained relative to both the prior quarter and the same quarter a year earlier.
What to watch
The filing highlights stronger operating cash flow in the first nine months, which may be a point of interest.